Literature DB >> 12020809

Antimony(V) complex formation with adenine nucleosides in aqueous solution.

Cynthia Demicheli1, Frédéric Frézard, Marc Lecouvey, Arlette Garnier-Suillerot.   

Abstract

Despite the clinical use of pentavalent antimonial drugs for over half a century, their mode of action against leishmaniasis remains poorly understood. In this paper, we investigated the ability of Sb(V) to form in aqueous solution complexes with adenine nucleosides and deoxynucleosides, using circular dichroism (CD) and (1)H and (13)C NMR spectroscopies. We report that the ribonucleosides, adenosine (A) and adenosine monophosphate (AMP), form in water complexes with Sb(V), as evidenced by the changes induced in their CD spectra. On the other hand, 2'-deoxyadenosine (dA) did not show such a change. CD titration of the ribonucleosides with Sb(V) suggests the formation of 1:2 Sb(V)-nucleoside complexes. NMR analysis indicates that Sb(V) binds to the sugar moiety at the 2' position. Furthermore, the incubation of the antimonial drug, meglumine antimonate, with adenosine at 37 degrees C led to the transfer of Sb(V) from its original ligand to the nucleoside molecule, at acidic pH (pH 5), but not at neutral pH (7.2). Our data therefore suggests that the formation of such complexes may take place in vivo within the acidic cell compartments, including the phagolysosome of macrophage in which Leishmania resides.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020809     DOI: 10.1016/s0304-4165(02)00198-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Synthesis and characterization of bismuth(III) and antimony(V) porphyrins: high antileishmanial activity against antimony-resistant parasite.

Authors:  Marcela Luísa Gomes; Gilson DeFreitas-Silva; Priscila Gomes dos Reis; Maria Norma Melo; Frédéric Frézard; Cynthia Demicheli; Ynara Marina Idemori
Journal:  J Biol Inorg Chem       Date:  2015-05-01       Impact factor: 3.358

2.  Meglumine Antimoniate (Glucantime) Causes Oxidative Stress-Derived DNA Damage in BALB/c Mice Infected by Leishmania (Leishmania) infantum.

Authors:  Vanessa Ribeiro Moreira; Luís Cláudio Lima de Jesus; Rossy-Eric Pereira Soares; Luis Douglas Miranda Silva; Bruno Araújo Serra Pinto; Maria Norma Melo; Antonio Marcus de Andrade Paes; Silma Regina Ferreira Pereira
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

3.  Bismuth(III) α-hydroxy carboxylates: highly selective toxicity of glycolates towards Leishmania major.

Authors:  Allan Loh; Yih Ching Ong; Victoria L Blair; Lukasz Kedzierski; Philip C Andrews
Journal:  J Biol Inorg Chem       Date:  2015-09-28       Impact factor: 3.358

4.  Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione.

Authors:  Siucheong Yan; Fei Li; Keyang Ding; Hongzhe Sun
Journal:  J Biol Inorg Chem       Date:  2003-06-21       Impact factor: 3.358

5.  Use of antimony in the treatment of leishmaniasis: current status and future directions.

Authors:  Arun Kumar Haldar; Pradip Sen; Syamal Roy
Journal:  Mol Biol Int       Date:  2011-06-08

Review 6.  Nanostructured delivery systems with improved leishmanicidal activity: a critical review.

Authors:  Natascia Bruni; Barbara Stella; Leonardo Giraudo; Carlo Della Pepa; Daniela Gastaldi; Franco Dosio
Journal:  Int J Nanomedicine       Date:  2017-07-26

7.  Study of conformational changes and protein aggregation of bovine serum albumin in presence of Sb(III) and Sb(V).

Authors:  Marcelo Verdugo; Jorge Ruiz Encinar; José Manuel Costa-Fernández; Mario Menendez-Miranda; Diego Bouzas-Ramos; Manuel Bravo; Waldo Quiroz
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

Review 8.  Pentavalent antimonials: new perspectives for old drugs.

Authors:  Frédéric Frézard; Cynthia Demicheli; Raul R Ribeiro
Journal:  Molecules       Date:  2009-06-30       Impact factor: 4.411

9.  Ascorbic acid reduces the genetic damage caused by miltefosine (hexadecylphosphocholine) in animals infected by Leishmania (Leishamnia) infantum without decreasing its antileishmanial activity.

Authors:  Patrícia Valéria Castelo-Branco; Hugo José Alves; Raissa Lacerda Pontes; Vera Lucia Maciel-Silva; Silma Regina Ferreira Pereira
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-12-13       Impact factor: 4.077

10.  The combination therapy of meglumine antimoniate and oxiranes (epoxy-α-lapachone and epoxymethyl-lawsone) enhance the leishmanicidal effect in mice infected by Leishmania (Leishmania) amazonensis.

Authors:  Luiz Filipe Gonçalves-Oliveira; Franklin Souza-Silva; Luzia Monteiro de Castro Côrtes; Laura Barral Veloso; Bernardo Acácio Santini Pereira; Lea Cysne-Finkelstein; Guilherme Curty Lechuga; Saulo Cabral Bourguignon; Fernando Almeida-Souza; Kátia da Silva Calabrese; Vitor Francisco Ferreira; Carlos Roberto Alves
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-08-12       Impact factor: 4.077

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.